HARRISBURG, PA — Pennsylvania has joined a multistate coalition securing $17.85 million in settlements with two generic drug manufacturers accused of conspiring to inflate prices and stifle competition, Attorney General Dave Sunday announced Monday.
The agreements resolve allegations that Lannett Company, Inc. and Bausch Health participated in long-running schemes to manipulate prices for certain generic prescription drugs sold nationwide, including in Pennsylvania, between May 2009 and December 2019. As part of the settlements, both companies agreed to cooperate with ongoing litigation against other pharmaceutical manufacturers and executives and to implement internal reforms aimed at complying with antitrust laws.
“Pennsylvania consumers rely on generic medications to keep health care affordable,” Sunday said. He said illegal price increases and reduced competition place an outsized burden on families, seniors, and patients on fixed incomes, adding that the settlement returns money to Pennsylvanians who were overcharged while reinforcing accountability across the drug industry.
The Lannett and Bausch agreements follow earlier multistate settlements totaling $49.1 million. Pennsylvania remains an active participant in broader antitrust litigation targeting numerous pharmaceutical manufacturers, with the first trial in that case expected in late 2026.
In a parallel move announced Monday, a coalition of 42 states and territories, including Pennsylvania, is filing a new lawsuit against Novartis and its generic subsidiary Sandoz. The complaint alleges the companies engaged in coordinated schemes to fix prices, allocate markets, and rig bids for dozens of generic prescription drugs sold across the United States.
Pennsylvanians who purchased generic prescription drugs manufactured by Lannett or Bausch between May 1, 2009, and December 31, 2019, may be eligible for compensation. Additional information and eligibility details are available by calling 1-866-290-0182, emailing info@AGGenericDrugs.com, or visiting www.AGGenericDrugs.com.
The settlements with Lannett and Bausch were joined by a broad coalition of states and territories spanning the country, reflecting what officials described as a sustained, coordinated effort to challenge anticompetitive practices in the generic drug market.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.